Our Products
Human staphylococcal vaccine
The vaccine is designed for prevention and treatment of human staphylococcal
infections.
It is non-toxic, does not generate bacterial resistance, and is affordable. It will address
an
urgent and ever growing need in vulnerable populations, where collectivization
occurs (i.e., the military, hospitals, nursing homes, and schools). A key target for our technology
are S.aureus infected individuals and individuals at increased risk of exposure to and infection
by S. aureus strains, including methicillin-resistant strains (MRSA), vancomycin-intermidiate strains (VISA) and vancomycin-resistant strains (VRSA).
ImmLab technology would have a role for pre-treatment of those facing elective surgery or any
other non-urgent invasive treatment.
Dairy-cow mastitis vaccine
The vaccine will prevent dairy-cow mastitis caused by the staphylococcus. The
enormous economic impact of this one disease to the American dairy farmer and,
subsequently, to the consumer is well established. Current therapies (antibiotics,
vaccines, management practices) are not sufficiently effective. Vaccination with this
product before infection will create herd immunity, saving millions of dollars annually to
this industry.
Small-animal vaccine
The vaccine can treat and prevent the most common skin infections in companion and
farm animals. These infections are caused by the staphylococcus. The animal contact
leads to human colonization, infection and further spread. Therefore, the use of this
vaccine will affect both veterinary and human medicine.
|
Copyright © 2011 Immunology Laboratories. All Rights Reserved. Design by z1lc services.